
Axoltis Pharma
Operator of a biotechnology company intended to treat patients suffering from severe neurological disorders. The company's drugs assist neural repair in treating patients with traumatic degenerative d...
Valuation
$0
Share Price
N/A
Total Raised
$25.5M
Last Round
N/A